Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to -$380000.0.

  • Avidity Biosciences' Other Non Operating Income fell 6379.31% to -$380000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 12833.94%. This contributed to the annual value of -$248000.0 for FY2024, which is 5824.92% up from last year.
  • As of Q3 2025, Avidity Biosciences' Other Non Operating Income stood at -$380000.0, which was down 6379.31% from -$651000.0 recorded in Q2 2025.
  • Avidity Biosciences' 5-year Other Non Operating Income high stood at $201000.0 for Q4 2024, and its period low was -$651000.0 during Q2 2025.
  • Moreover, its 5-year median value for Other Non Operating Income was -$46000.0 (2021), whereas its average is -$127736.8.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first plummeted by 800000.0% in 2023, then soared by 29142.86% in 2024.
  • Avidity Biosciences' Other Non Operating Income (Quarter) stood at -$46000.0 in 2021, then skyrocketed by 60.87% to -$18000.0 in 2022, then crashed by 483.33% to -$105000.0 in 2023, then skyrocketed by 291.43% to $201000.0 in 2024, then plummeted by 289.05% to -$380000.0 in 2025.
  • Its last three reported values are -$380000.0 in Q3 2025, -$651000.0 for Q2 2025, and -$435000.0 during Q1 2025.